APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceutical Transport Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Radiopharmaceutical Transport Service Market Analysis and Forecast 2026-2032

3 July 2026185 pages

Choose your research edition.

Industry ResearchRadiopharmaceutical Transport Service Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceutical Transport Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Radiopharmaceutical Transport Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceutical Transport Service Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceutical Transport Service Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

The global Radiopharmaceutical Transport Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Radiopharmaceutical Transport Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Radiopharmaceutical Transport Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Radiopharmaceutical Transport Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Radiopharmaceutical Transport Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Radiopharmaceutical Transport Service include AirNet II, Circle Express, Life Couriers, MNX Global Logistics, Kalitta Charters, Perlamar Ltd, Isotopes, Global Airfreight International and Ameriflight, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Radiopharmaceutical Transport Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radiopharmaceutical Transport Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Radiopharmaceutical Transport Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiopharmaceutical Transport Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiopharmaceutical Transport Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Radiopharmaceutical Transport Service revenue, projected growth trends, production technology, application and end-user industry.

Radiopharmaceutical Transport Service Segment by Company

AirNet II

Circle Express

Life Couriers

MNX Global Logistics

Kalitta Charters

Perlamar Ltd

Isotopes

Global Airfreight International

Ameriflight

SWAN Isotopen AG

Medi-Ops

Crisago

Yantai Dalong Logistics Co., Ltd.

Sinotau Pharmaceutical Group

Ichimiya Transport

Transnuclear

SK Group

Radiopharmaceutical Transport Service Segment by Type

Short-half-life Radionuclide Transport

Long-half-life Radionuclide Transport

Radiopharmaceutical Transport Service Segment by Application

Radiopharmaceutical Manufacturers

Hospitals and Medical Institutions

Others

Radiopharmaceutical Transport Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical Transport Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical Transport Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical Transport Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Radiopharmaceutical Transport Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Radiopharmaceutical Transport Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical Transport Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiopharmaceutical Transport Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Short-half-life Radionuclide Transport Major Player Table 3. Long-half-life Radionuclide Transport Major Player Table 4. Global Radiopharmaceutical Transport Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Radiopharmaceutical Manufacturers Major Player Table 6. Hospitals and Medical Institutions Major Player Table 7. Others Major Player Table 8. Radiopharmaceutical Transport Service Industry Trends Table 9. Radiopharmaceutical Transport Service Industry Drivers Table 10. Radiopharmaceutical Transport Service Industry Opportunities and Challenges Table 11. Radiopharmaceutical Transport Service Industry Restraints Table 12. Global Radiopharmaceutical Transport Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Radiopharmaceutical Transport Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Radiopharmaceutical Transport Service Market Share by Region (2021-2026) Table 15. Global Radiopharmaceutical Transport Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Radiopharmaceutical Transport Service Market Share by Region (2027-2032) Table 17. Global Radiopharmaceutical Transport Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Radiopharmaceutical Transport Service Revenue Market Share by Players (2021-2026) Table 19. Global Radiopharmaceutical Transport Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Radiopharmaceutical Transport Service Key Players Headquarters & Area Served Table 21. Global Radiopharmaceutical Transport Service Players, Product Type & Application Table 22. Global Radiopharmaceutical Transport Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Radiopharmaceutical Transport Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Radiopharmaceutical Transport Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Radiopharmaceutical Transport Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Radiopharmaceutical Transport Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Radiopharmaceutical Transport Service Revenue Market Share by Type (2021-2026) Table 29. Global Radiopharmaceutical Transport Service Revenue Market Share by Type (2027-2032) Table 30. Global Radiopharmaceutical Transport Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Radiopharmaceutical Transport Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Radiopharmaceutical Transport Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Radiopharmaceutical Transport Service Revenue Market Share by Application (2021-2026) Table 34. Global Radiopharmaceutical Transport Service Revenue Market Share by Application (2027-2032) Table 35. AirNet II Company Information Table 36. AirNet II Business Overview Table 37. AirNet II Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AirNet II Radiopharmaceutical Transport Service Product Portfolio Table 39. AirNet II Recent Development Table 40. Circle Express Company Information Table 41. Circle Express Business Overview Table 42. Circle Express Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Circle Express Radiopharmaceutical Transport Service Product Portfolio Table 44. Circle Express Recent Development Table 45. Life Couriers Company Information Table 46. Life Couriers Business Overview Table 47. Life Couriers Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Life Couriers Radiopharmaceutical Transport Service Product Portfolio Table 49. Life Couriers Recent Development Table 50. MNX Global Logistics Company Information Table 51. MNX Global Logistics Business Overview Table 52. MNX Global Logistics Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. MNX Global Logistics Radiopharmaceutical Transport Service Product Portfolio Table 54. MNX Global Logistics Recent Development Table 55. Kalitta Charters Company Information Table 56. Kalitta Charters Business Overview Table 57. Kalitta Charters Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Kalitta Charters Radiopharmaceutical Transport Service Product Portfolio Table 59. Kalitta Charters Recent Development Table 60. Perlamar Ltd Company Information Table 61. Perlamar Ltd Business Overview Table 62. Perlamar Ltd Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Perlamar Ltd Radiopharmaceutical Transport Service Product Portfolio Table 64. Perlamar Ltd Recent Development Table 65. Isotopes Company Information Table 66. Isotopes Business Overview Table 67. Isotopes Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Isotopes Radiopharmaceutical Transport Service Product Portfolio Table 69. Isotopes Recent Development Table 70. Global Airfreight International Company Information Table 71. Global Airfreight International Business Overview Table 72. Global Airfreight International Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Global Airfreight International Radiopharmaceutical Transport Service Product Portfolio Table 74. Global Airfreight International Recent Development Table 75. Ameriflight Company Information Table 76. Ameriflight Business Overview Table 77. Ameriflight Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Ameriflight Radiopharmaceutical Transport Service Product Portfolio Table 79. Ameriflight Recent Development Table 80. SWAN Isotopen AG Company Information Table 81. SWAN Isotopen AG Business Overview Table 82. SWAN Isotopen AG Radiopharmaceutical Transport Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. SWAN Isotopen AG Radiopharmaceutical Transport Service Product Portfolio Table 84. SWAN Isotopen AG Recent Development Table 85. Medi-Ops Company Information Table 86. Medi-Ops Business Overview Table 87. Medi-Ops Radiopharmaceutical Transport Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Medi-Ops Radiopharmaceutical Transport Service Product Portfolio Table 89. Medi-Ops Recent Development Table 90. Crisago Company Information Table 91. Crisago Business Overview Table 92. Crisago Radiopharmaceutical Transport Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Crisago Radiopharmaceutical Transport Service Product Portfolio Table 94. Crisago Recent Development Table 95. Yantai Dalong Logistics Co., Ltd. Company Information Table 96. Yantai Dalong Logistics Co., Ltd. Business Overview Table 97. Yantai Dalong Logistics Co., Ltd. Radiopharmaceutical Transport Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Yantai Dalong Logistics Co., Ltd. Radiopharmaceutical Transport Service Product Portfolio Table 99. Yantai Dalong Logistics Co., Ltd. Recent Development Table 100. Sinotau Pharmaceutical Group Company Information Table 101. Sinotau Pharmaceutical Group Business Overview Table 102. Sinotau Pharmaceutical Group Radiopharmaceutical Transport Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Sinotau Pharmaceutical Group Radiopharmaceutical Transport Service Product Portfolio Table 104. Sinotau Pharmaceutical Group Recent Development Table 105. Ichimiya Transport Company Information Table 106. Ichimiya Transport Business Overview Table 107. Ichimiya Transport Radiopharmaceutical Transport Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Ichimiya Transport Radiopharmaceutical Transport Service Product Portfolio Table 109. Ichimiya Transport Recent Development Table 110. Transnuclear Company Information Table 111. Transnuclear Business Overview Table 112. Transnuclear Radiopharmaceutical Transport Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Transnuclear Radiopharmaceutical Transport Service Product Portfolio Table 114. Transnuclear Recent Development Table 115. SK Group Company Information Table 116. SK Group Business Overview Table 117. SK Group Radiopharmaceutical Transport Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. SK Group Radiopharmaceutical Transport Service Product Portfolio Table 119. SK Group Recent Development Table 120. North America Radiopharmaceutical Transport Service Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Radiopharmaceutical Transport Service Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Radiopharmaceutical Transport Service Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Radiopharmaceutical Transport Service Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Radiopharmaceutical Transport Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Radiopharmaceutical Transport Service Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Radiopharmaceutical Transport Service Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Radiopharmaceutical Transport Service Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Radiopharmaceutical Transport Service Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Radiopharmaceutical Transport Service Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Radiopharmaceutical Transport Service Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Radiopharmaceutical Transport Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Radiopharmaceutical Transport Service Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Radiopharmaceutical Transport Service Revenue by Country (US$ Million) & (2027-2032) Table 134. China Radiopharmaceutical Transport Service Revenue by Type (2021-2026) & (US$ Million) Table 135. China Radiopharmaceutical Transport Service Revenue by Type (2027-2032) & (US$ Million) Table 136. China Radiopharmaceutical Transport Service Revenue by Application (2021-2026) & (US$ Million) Table 137. China Radiopharmaceutical Transport Service Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Radiopharmaceutical Transport Service Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Radiopharmaceutical Transport Service Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Radiopharmaceutical Transport Service Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Radiopharmaceutical Transport Service Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Radiopharmaceutical Transport Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Radiopharmaceutical Transport Service Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Radiopharmaceutical Transport Service Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Radiopharmaceutical Transport Service Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Radiopharmaceutical Transport Service Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Radiopharmaceutical Transport Service Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Radiopharmaceutical Transport Service Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Radiopharmaceutical Transport Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Radiopharmaceutical Transport Service Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Radiopharmaceutical Transport Service Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Radiopharmaceutical Transport Service Image Figure 2. Global Radiopharmaceutical Transport Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceutical Transport Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Short-half-life Radionuclide Transport Image Figure 5. Long-half-life Radionuclide Transport Image Figure 6. Global Radiopharmaceutical Transport Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Radiopharmaceutical Transport Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Radiopharmaceutical Manufacturers Image Figure 9. Hospitals and Medical Institutions Image Figure 10. Others Image Figure 11. Global Radiopharmaceutical Transport Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Radiopharmaceutical Transport Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Radiopharmaceutical Transport Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Radiopharmaceutical Transport Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Radiopharmaceutical Transport Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Radiopharmaceutical Transport Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Radiopharmaceutical Transport Service Revenue Market Share by Type (2021-2032) Figure 19. Global Radiopharmaceutical Transport Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Radiopharmaceutical Transport Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Radiopharmaceutical Transport Service Revenue Market Share by Application (2021-2032) Figure 22. North America Radiopharmaceutical Transport Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032) Figure 24. North America Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032) Figure 25. North America Radiopharmaceutical Transport Service Revenue Share by Country (2021-2032) Figure 26. United States Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Radiopharmaceutical Transport Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032) Figure 31. Europe Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032) Figure 32. Europe Radiopharmaceutical Transport Service Revenue Share by Country (2021-2032) Figure 33. Germany Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Radiopharmaceutical Transport Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032) Figure 43. China Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032) Figure 44. Asia Radiopharmaceutical Transport Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032) Figure 46. Asia Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032) Figure 47. Asia Radiopharmaceutical Transport Service Revenue Share by Region (2021-2032) Figure 48. Japan Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Radiopharmaceutical Transport Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Radiopharmaceutical Transport Service Revenue Share by Country (2021-2032) Figure 58. Brazil Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Radiopharmaceutical Transport Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Short-half-life Radionuclide Transport
  • Long-half-life Radionuclide Transport
Applications
  • Radiopharmaceutical Manufacturers
  • Hospitals and Medical Institutions
  • Others
Companies covered
  • AirNet II
  • Circle Express
  • Life Couriers
  • MNX Global Logistics
  • Kalitta Charters
  • Perlamar Ltd
  • Isotopes
  • Global Airfreight International
  • Ameriflight
  • SWAN Isotopen AG
  • Medi-Ops
  • Crisago
  • Yantai Dalong Logistics Co., Ltd.
  • Sinotau Pharmaceutical Group
  • Ichimiya Transport
  • Transnuclear
  • SK Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radiopharmaceutical Transport Service Market by Type
  3. 1.2.1 Global Radiopharmaceutical Transport Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Short-half-life Radionuclide Transport
  5. 1.2.3 Long-half-life Radionuclide Transport
  6. 1.3 Radiopharmaceutical Transport Service Market by Application
  7. 1.3.1 Global Radiopharmaceutical Transport Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Radiopharmaceutical Manufacturers
  9. 1.3.3 Hospitals and Medical Institutions
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Radiopharmaceutical Transport Service Market Dynamics
  1. 2.1 Radiopharmaceutical Transport Service Industry Trends
  2. 2.2 Radiopharmaceutical Transport Service Industry Drivers
  3. 2.3 Radiopharmaceutical Transport Service Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceutical Transport Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Radiopharmaceutical Transport Service Market Perspective (2021-2032)
  2. 3.2 Global Radiopharmaceutical Transport Service Growth Trends by Region
  3. 3.2.1 Global Radiopharmaceutical Transport Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radiopharmaceutical Transport Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Radiopharmaceutical Transport Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Radiopharmaceutical Transport Service Revenue by Players
  2. 4.1.1 Global Radiopharmaceutical Transport Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Radiopharmaceutical Transport Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Radiopharmaceutical Transport Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radiopharmaceutical Transport Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Radiopharmaceutical Transport Service Key Players Headquarters & Area Served
  7. 4.4 Global Radiopharmaceutical Transport Service Players, Product Type & Application
  8. 4.5 Global Radiopharmaceutical Transport Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Radiopharmaceutical Transport Service Market CR5 and HHI
  11. 4.6.3 2025 Radiopharmaceutical Transport Service Tier 1, Tier 2, and Tier 3
5 Radiopharmaceutical Transport Service Market Size by Type
  1. 5.1 Global Radiopharmaceutical Transport Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Radiopharmaceutical Transport Service Revenue by Type (2021-2032)
  3. 5.3 Global Radiopharmaceutical Transport Service Revenue Market Share by Type (2021-2032)
6 Radiopharmaceutical Transport Service Market Size by Application
  1. 6.1 Global Radiopharmaceutical Transport Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Radiopharmaceutical Transport Service Revenue by Application (2021-2032)
  3. 6.3 Global Radiopharmaceutical Transport Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AirNet II
  2. 7.1.1 AirNet II Company Information
  3. 7.1.2 AirNet II Business Overview
  4. 7.1.3 AirNet II Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AirNet II Radiopharmaceutical Transport Service Product Portfolio
  6. 7.1.5 AirNet II Recent Developments
  7. 7.2 Circle Express
  8. 7.2.1 Circle Express Company Information
  9. 7.2.2 Circle Express Business Overview
  10. 7.2.3 Circle Express Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Circle Express Radiopharmaceutical Transport Service Product Portfolio
  12. 7.2.5 Circle Express Recent Developments
  13. 7.3 Life Couriers
  14. 7.3.1 Life Couriers Company Information
  15. 7.3.2 Life Couriers Business Overview
  16. 7.3.3 Life Couriers Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Life Couriers Radiopharmaceutical Transport Service Product Portfolio
  18. 7.3.5 Life Couriers Recent Developments
  19. 7.4 MNX Global Logistics
  20. 7.4.1 MNX Global Logistics Company Information
  21. 7.4.2 MNX Global Logistics Business Overview
  22. 7.4.3 MNX Global Logistics Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 MNX Global Logistics Radiopharmaceutical Transport Service Product Portfolio
  24. 7.4.5 MNX Global Logistics Recent Developments
  25. 7.5 Kalitta Charters
  26. 7.5.1 Kalitta Charters Company Information
  27. 7.5.2 Kalitta Charters Business Overview
  28. 7.5.3 Kalitta Charters Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Kalitta Charters Radiopharmaceutical Transport Service Product Portfolio
  30. 7.5.5 Kalitta Charters Recent Developments
  31. 7.6 Perlamar Ltd
  32. 7.6.1 Perlamar Ltd Company Information
  33. 7.6.2 Perlamar Ltd Business Overview
  34. 7.6.3 Perlamar Ltd Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Perlamar Ltd Radiopharmaceutical Transport Service Product Portfolio
  36. 7.6.5 Perlamar Ltd Recent Developments
  37. 7.7 Isotopes
  38. 7.7.1 Isotopes Company Information
  39. 7.7.2 Isotopes Business Overview
  40. 7.7.3 Isotopes Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Isotopes Radiopharmaceutical Transport Service Product Portfolio
  42. 7.7.5 Isotopes Recent Developments
  43. 7.8 Global Airfreight International
  44. 7.8.1 Global Airfreight International Company Information
  45. 7.8.2 Global Airfreight International Business Overview
  46. 7.8.3 Global Airfreight International Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Global Airfreight International Radiopharmaceutical Transport Service Product Portfolio
  48. 7.8.5 Global Airfreight International Recent Developments
  49. 7.9 Ameriflight
  50. 7.9.1 Ameriflight Company Information
  51. 7.9.2 Ameriflight Business Overview
  52. 7.9.3 Ameriflight Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Ameriflight Radiopharmaceutical Transport Service Product Portfolio
  54. 7.9.5 Ameriflight Recent Developments
  55. 7.10 SWAN Isotopen AG
  56. 7.10.1 SWAN Isotopen AG Company Information
  57. 7.10.2 SWAN Isotopen AG Business Overview
  58. 7.10.3 SWAN Isotopen AG Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 SWAN Isotopen AG Radiopharmaceutical Transport Service Product Portfolio
  60. 7.10.5 SWAN Isotopen AG Recent Developments
  61. 7.11 Medi-Ops
  62. 7.11.1 Medi-Ops Company Information
  63. 7.11.2 Medi-Ops Business Overview
  64. 7.11.3 Medi-Ops Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Medi-Ops Radiopharmaceutical Transport Service Product Portfolio
  66. 7.11.5 Medi-Ops Recent Developments
  67. 7.12 Crisago
  68. 7.12.1 Crisago Company Information
  69. 7.12.2 Crisago Business Overview
  70. 7.12.3 Crisago Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Crisago Radiopharmaceutical Transport Service Product Portfolio
  72. 7.12.5 Crisago Recent Developments
  73. 7.13 Yantai Dalong Logistics Co., Ltd.
  74. 7.13.1 Yantai Dalong Logistics Co., Ltd. Company Information
  75. 7.13.2 Yantai Dalong Logistics Co., Ltd. Business Overview
  76. 7.13.3 Yantai Dalong Logistics Co., Ltd. Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Yantai Dalong Logistics Co., Ltd. Radiopharmaceutical Transport Service Product Portfolio
  78. 7.13.5 Yantai Dalong Logistics Co., Ltd. Recent Developments
  79. 7.14 Sinotau Pharmaceutical Group
  80. 7.14.1 Sinotau Pharmaceutical Group Company Information
  81. 7.14.2 Sinotau Pharmaceutical Group Business Overview
  82. 7.14.3 Sinotau Pharmaceutical Group Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sinotau Pharmaceutical Group Radiopharmaceutical Transport Service Product Portfolio
  84. 7.14.5 Sinotau Pharmaceutical Group Recent Developments
  85. 7.15 Ichimiya Transport
  86. 7.15.1 Ichimiya Transport Company Information
  87. 7.15.2 Ichimiya Transport Business Overview
  88. 7.15.3 Ichimiya Transport Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Ichimiya Transport Radiopharmaceutical Transport Service Product Portfolio
  90. 7.15.5 Ichimiya Transport Recent Developments
  91. 7.16 Transnuclear
  92. 7.16.1 Transnuclear Company Information
  93. 7.16.2 Transnuclear Business Overview
  94. 7.16.3 Transnuclear Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Transnuclear Radiopharmaceutical Transport Service Product Portfolio
  96. 7.16.5 Transnuclear Recent Developments
  97. 7.17 SK Group
  98. 7.17.1 SK Group Company Information
  99. 7.17.2 SK Group Business Overview
  100. 7.17.3 SK Group Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 SK Group Radiopharmaceutical Transport Service Product Portfolio
  102. 7.17.5 SK Group Recent Developments
8 North America
  1. 8.1 North America Radiopharmaceutical Transport Service Revenue (2021-2032)
  2. 8.2 North America Radiopharmaceutical Transport Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Radiopharmaceutical Transport Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Radiopharmaceutical Transport Service Revenue by Type (2027-2032)
  5. 8.3 North America Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Radiopharmaceutical Transport Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Radiopharmaceutical Transport Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Radiopharmaceutical Transport Service Revenue by Application (2027-2032)
  9. 8.5 North America Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Radiopharmaceutical Transport Service Revenue by Country
  11. 8.6.1 North America Radiopharmaceutical Transport Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Radiopharmaceutical Transport Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Radiopharmaceutical Transport Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Radiopharmaceutical Transport Service Revenue (2021-2032)
  2. 9.2 Europe Radiopharmaceutical Transport Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Radiopharmaceutical Transport Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Radiopharmaceutical Transport Service Revenue by Type (2027-2032)
  5. 9.3 Europe Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Radiopharmaceutical Transport Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Radiopharmaceutical Transport Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Radiopharmaceutical Transport Service Revenue by Application (2027-2032)
  9. 9.5 Europe Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Radiopharmaceutical Transport Service Revenue by Country
  11. 9.6.1 Europe Radiopharmaceutical Transport Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Radiopharmaceutical Transport Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Radiopharmaceutical Transport Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Radiopharmaceutical Transport Service Revenue (2021-2032)
  2. 10.2 China Radiopharmaceutical Transport Service Revenue by Type (2021-2032)
  3. 10.2.1 China Radiopharmaceutical Transport Service Revenue by Type (2021-2026)
  4. 10.2.2 China Radiopharmaceutical Transport Service Revenue by Type (2027-2032)
  5. 10.3 China Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032)
  6. 10.4 China Radiopharmaceutical Transport Service Revenue by Application (2021-2032)
  7. 10.4.1 China Radiopharmaceutical Transport Service Revenue by Application (2021-2026)
  8. 10.4.2 China Radiopharmaceutical Transport Service Revenue by Application (2027-2032)
  9. 10.5 China Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radiopharmaceutical Transport Service Revenue (2021-2032)
  2. 11.2 Asia Radiopharmaceutical Transport Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Radiopharmaceutical Transport Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Radiopharmaceutical Transport Service Revenue by Type (2027-2032)
  5. 11.3 Asia Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Radiopharmaceutical Transport Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Radiopharmaceutical Transport Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Radiopharmaceutical Transport Service Revenue by Application (2027-2032)
  9. 11.5 Asia Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Radiopharmaceutical Transport Service Revenue by Country
  11. 11.6.1 Asia Radiopharmaceutical Transport Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Radiopharmaceutical Transport Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Radiopharmaceutical Transport Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radiopharmaceutical Transport Service Revenue (2021-2032)
  2. 12.2 SAMEA Radiopharmaceutical Transport Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Radiopharmaceutical Transport Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Radiopharmaceutical Transport Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Radiopharmaceutical Transport Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Radiopharmaceutical Transport Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Radiopharmaceutical Transport Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Radiopharmaceutical Transport Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Radiopharmaceutical Transport Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Radiopharmaceutical Transport Service Revenue by Country
  11. 12.6.1 SAMEA Radiopharmaceutical Transport Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Radiopharmaceutical Transport Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Radiopharmaceutical Transport Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst